PROSIGNA Trademark
PROSIGNA is a USPTO trademark filed by VERACYTE, INC.. Status: Cancelled.
Prosecution Summary
Trademark Summary
The mark PROSIGNA consists of the word "prosigna" with a starburst design above the letter "i" and covers diagnostic reagents and kits for scientific or research use and for medical use primarily in the field of breast cancer across International Classes 001 and 005 (with references to other cancers in brackets), along with classifications in other classes including 006, 010, 018, 026, 044, 046, 051, and 052. The mark is owned by Veracyte, Inc., a Delaware corporation with an address in South San Francisco, California, following an assignment from original owner NanoString Technologies, Inc. It is currently cancelled due to failure to file an acceptable Section 8 declaration, with cancellation effective February 28, 2025, and certain classes expl
Trademark Facts
| Mark | PROSIGNA |
|---|---|
| Serial Number | 85783446 |
| Registration Number | 4585209 |
| Status | Cancelled |
| Filing Date | 2012-11-19 |
| Registration Date | 2014-08-12 |
| Mark Type | Combined |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals) |
| Owner | VERACYTE, INC. |
| Attorney of Record | Rosaleen H. Chou |
| Prosecution Events | 53 |
| Latest Event | CAEX on 2025-02-28 |
Goods & Services
diagnostic reagents for medical use in the field of [ cancer ] * breast, [ovarian, bladder, lung, pancreatic, or prostate ]cancer *; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of [cancer ] * breast, [ ovarian, bladder, lung, pancreatic, or prostate] cancer *; diagnostic reagents for scientific or research use in the field of [ cancer ] breast, [ ovarian, bladder, lung, pancreatic, or prostate ] cancer; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of [ cancer ] breast [, ovarian, bladder, lung, pancreatic, or prostate] cancer